Author

SUNGHEE HONG

OpenAlex ID: A5108943512

774-P: Robust Antiobesity Effect and Mechanistic Insights of HM15275, a Novel Long-Acting GLP-1/GIP/Glucagon Triple Agonist in Animal Model of Obesity

2025 · SANG HYUN PARK, YOHAN KIM, et al. · Diabetes · 1

842-P: A Novel CRFR2-Selective UCN2 Analog, HM17321, Improves Glycemic Control across Multiple Preclinical Models

2025 · SEON MYEONG LEE, EUNSEON KIM, et al. · Diabetes

843-P: A Novel CRFR2 Selective UCN2 Analog, HM17321, Facilitates Weight Loss and Improves Body Composition across Animal Models of Obesity

2025 · JUNG KUK KIM, SEON MYEONG LEE, et al. · Diabetes

776-P: Potent Weight Loss and Favorable Glycemic Control Effects of a Novel Long-Acting GLP-1/GIP/GCG Triple Agonist, HM15275, in Animal Models

2024 · SANG HYUN PARK, YOHAN KIM, et al. · Diabetes

799-P: Nephroprotective Effects of a Novel Long-Acting GLP-1/GIP/GCG Triple Agonist, HM15275, in Preclinical Models of Acute and Chronic Kidney Diseases

2024 · SEON MYEONG LEE, EUNJIN PARK, et al. · Diabetes

798-P: Potential Cardioprotective Effects of HM15275, a Novel, Long-Acting GLP-1/GIP/GCG Triple Agonist, in Animal Models of Hypertension

2024 · SEON MYEONG LEE, JUNG KUK KIM, et al. · Diabetes

Works count: 6

Citation count: 1

H-index: 1

I10-index: